Cubist Systematic Strategies, LLC Uni Qure N.V. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 226,057 shares of QURE stock, worth $3.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

226,057

Previous 25,494 786.71%

Holding current value

$3.89 Million

Previous $114,000 877.19%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.78 - $10.12 $758,128 - $2.03 Million	200,563 Added 786.71%	226,057 $1.11 Million
Q2 2024 Aug 14, 2024	BUY	$4.39 - $5.43 $63,453 - $78,485	14,454 Added 130.92%	25,494 $114,000
Q1 2024 May 15, 2024	SELL	$4.82 - $6.93 $1.27 Million - $1.83 Million	-263,408 Reduced 95.98%	11,040 $57,000
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $435,120 - $639,155	77,286 Added 39.2%	274,448 $1.86 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $1.32 Million - $2.33 Million	197,162 New	197,162 $1.32 Million
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $1.3 Million - $1.95 Million	71,524 Added 6461.07%	72,631 $1.65 Million
Q1 2022 May 16, 2022	SELL	$14.54 - $21.5 $17,215 - $25,456	-1,184 Reduced 51.68%	1,107 $20,000
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $232,962 - $414,475	-11,510 Reduced 83.4%	2,291 $48,000
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $348,325 - $511,842	-13,392 Reduced 49.25%	13,801 $442,000
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $410,379 - $508,968	13,693 Added 101.43%	27,193 $838,000
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $52,982 - $76,158	-1,812 Reduced 11.83%	13,500 $455,000
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $237,269 - $340,097	6,712 Added 78.05%	15,312 $553,000
Q3 2020 Nov 16, 2020	SELL	$35.98 - $47.66 $60,806 - $80,545	-1,690 Reduced 16.42%	8,600 $317,000
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $463,667 - $697,044	10,290 New	10,290 $464,000
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $175,563 - $324,580	-4,388 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $24,208 - $48,652	-652 Reduced 12.94%	4,388 $314,000
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $108,200 - $211,123	-2,749 Reduced 35.29%	5,040 $198,000
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $410,947 - $640,177	7,789 New	7,789 $609,000
Q4 2018 Feb 14, 2019	SELL	$22.8 - $33.93 $143,320 - $213,283	-6,286 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$29.75 - $43.08 $550,285 - $796,850	-18,497 Reduced 74.64%	6,286 $229,000
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $544,234 - $989,833	24,783 New	24,783 $937,000
Q1 2018 May 15, 2018	SELL	$17.1 - $26.61 $9,148 - $14,236	-535 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$9.47 - $19.59 $5,066 - $10,480	535	535 $10,000

Others Institutions Holding QURE

# of Institutions

154

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $805M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Uni Qure N.V. Transaction History